Cargando…
Advancing Alzheimer’s Therapeutics: Exploring the Impact of Physical Exercise in Animal Models and Patients
Alzheimer’s disease (AD) is the main neurodegenerative disorder characterized by several pathophysiological features, including the misfolding of the tau protein and the amyloid beta (Aβ) peptide, neuroinflammation, oxidative stress, synaptic dysfunction, metabolic alterations, and cognitive impairm...
Autores principales: | Andrade-Guerrero, Jesús, Rodríguez-Arellano, Paola, Barron-Leon, Nayeli, Orta-Salazar, Erika, Ledesma-Alonso, Carlos, Díaz-Cintra, Sofía, Soto-Rojas, Luis O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648553/ https://www.ncbi.nlm.nih.gov/pubmed/37947609 http://dx.doi.org/10.3390/cells12212531 |
Ejemplares similares
-
Effects of Voluntary Physical Exercise on the Neurovascular Unit in a Mouse Model of Alzheimer’s Disease
por: Andrade-Guerrero, Jesús, et al.
Publicado: (2023) -
Alzheimer’s Disease: An Updated Overview of Its Genetics
por: Andrade-Guerrero, Jesús, et al.
Publicado: (2023) -
Editorial: Nutrition and prevention of Alzheimer's disease
por: Perez-Cruz, Claudia, et al.
Publicado: (2015) -
Correction to: Protective effects of intracerebroventricular adiponectin against olfactory impairments in an amyloid β(1–42) rat model
por: Guzmán-Ruiz, Mara A., et al.
Publicado: (2021) -
Protective effects of intracerebroventricular adiponectin against olfactory impairments in an amyloid β(1–42) rat model
por: Guzmán-Ruiz, Mara A., et al.
Publicado: (2021)